According to the World Health Organisation (WHO),
osteoporosis is second only to cardiovascular disease as
a leading health care problem. World-wide about one in
three women and one in eight men over the age of 50 risk
having an osteoporotic fracture during their lifetimes.
Moreover, the number of hip fractures is expected to
increase from 1.7 million in 1990 to 6.3 million in 2050
because of the increasingly ageing world
population.
Annual direct medical costs to treat
an estimated 2.3 million osteoporosis fractures in
Europe and the United States together amount to US$27
billion.
What is osteoporosis? Osteoporosis is a
disease affecting the bones which is characterised by a
decrease in bone mass and density that increases the
risk of broken bones, particularly in the spine, wrist,
hip, pelvis and upper arm. The disease occurs in women
after the menopause.
Unfortunately most people
don't know they have osteoporosis until they break a
bone. As such, a new WHO study has stated that early
detection of low bone density could significantly reduce
the impact of osteoporosis.
Osteoporosis can be diagnosed relatively easily
by:
-
medical history
-
basic investigations, including x-rays
-
bone mass density – QCT (quantitative computed
tomography) – QUS (quantitative ultrasound
scanning)
-
DXA (DEXA) dual energy x-ray absorptiometry
-
biochemical markers of bone turnover (serum +
urine) – bone formation – bone breakdown
Management of osteoporosis Strategies for
the management of osteoporosis include:
-
A diet which maintains normal body weight
throughout life and provides a calcium intake of some
1000 mg per day from late childhood onwards
-
Encouragement of a physically active lifestyle
-
Avoiding smoking and heavy drinking
-
Minimisation of cortisone use and potential
administration of osteoporosis prophylaxis medication
when cortisone is given
-
Calcium and vitamin D supplementation
-
Drug therapy includes hormone replacement therapy
in postmenopausal women, bisphosphonates, and active
vitamin D. |
|